A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Clinical trial NCT05503797 · RECRUITING
Trial details
- NCT number
- NCT05503797
- Sponsor
- Fore Biotherapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2027-12-31
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.